Bionano Genomics, Inc. (BNGO)
$1.17-$0.04 (-3.31%) Today
Alka Chaubey - OfficerBionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 4,000 | $5K |
| Grant or award | 4 | 89,000 | |
| Tax withholding / forfeiture | 4 | 82 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
29 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Albert Luderer - Officer | Open-market purchase | Common Stock | 4,000 | $1.22 | $5K | |
| Mark Adamchak - Officer | Grant or award | Stock Option (Right to Buy) | 5,000 | $0.00 | - | |
| Jonathan V. Dixon - Officer | Grant or award | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Mark Oldakowski - Officer | Grant or award | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Alex Reid Hastie - Officer | Grant or award | Stock Option (Right to Buy) | 54,000 | $0.00 | - | |
| Jonathan V. Dixon - Officer | Tax withholding / forfeiture | Common Stock | 24 | $1.30 | $31 | |
| Mark Oldakowski - Officer | Tax withholding / forfeiture | Common Stock | 27 | $1.30 | $35 | |
| Alka Chaubey - Officer | Tax withholding / forfeiture | Common Stock | 24 | $1.30 | $31 | |
| Mark Adamchak - Officer | Tax withholding / forfeiture | Common Stock | 7 | $1.30 | $9 | |
| Aleksandar Rajkovic | Grant or award | Stock Option (Right to Buy) | 9,149 | $0.00 | - | |
| Yvonne Linney | Grant or award | Stock Option (Right to Buy) | 9,149 | $0.00 | - | |
| Kristiina Md Vuori | Grant or award | Stock Option (Right to Buy) | 9,149 | $0.00 | - | |
| Christopher J. Twomey | Grant or award | Stock Option (Right to Buy) | 9,149 | $0.00 | - | |
| David L. Barker | Grant or award | Stock Option (Right to Buy) | 9,149 | $0.00 | - | |
| Alka Chaubey - Officer | Tax withholding / forfeiture | Common Stock | 18 | $1.10 | $20 | |
| Mark Adamchak - Officer | Tax withholding / forfeiture | Common Stock | 3 | $1.10 | $3 | |
| Jonathan V. Dixon - Officer | Tax withholding / forfeiture | Common Stock | 6 | $1.10 | $7 | |
| Mark Oldakowski - Officer | Tax withholding / forfeiture | Common Stock | 20 | $1.10 | $22 | |
 R. Erik Holmlin - Officer | Tax withholding / forfeiture | Common Stock | 51 | $1.10 | $56 | |
| Mark Adamchak - Officer | Grant or award | Stock Option (Right to Buy) | 10,890 | $0.00 | - | |
| Alka Chaubey - Officer | Grant or award | Stock Option (Right to Buy) | 27,737 | $0.00 | - | |
| Mark Oldakowski - Officer | Grant or award | Stock Option (Right to Buy) | 27,737 | $0.00 | - | |
| Jonathan V. Dixon - Officer | Grant or award | Stock Option (Right to Buy) | 26,117 | $0.00 | - | |
| R. Erik Holmlin - Officer | Grant or award | Stock Option (Right to Buy) | 69,484 | $0.00 | - | |
| Alka Chaubey - Officer | Tax withholding / forfeiture | Common Stock | 51 | $4.06 | $207 | |
| Mark Oldakowski - Officer | Tax withholding / forfeiture | Common Stock | 59 | $4.06 | $240 | |
| Christopher J. Twomey - Director | Grant or award | Stock Option (Right to Buy) | 2,775 | $0.00 | - | |
| David L. Barker - Director | Grant or award | Stock Option (Right to Buy) | 2,775 | $0.00 | - | |
| Mark Adamchak - Officer | Grant or award | Stock Option (Right to Buy) | 17,500 | $0.00 | - |
Bionano Genomics, Inc. (BNGO) had 9 insider filings in the last 90 days, with the most recent on 2026-08-21. The full record for BNGO runs to 29 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
1 insider purchase of BNGO was filed in the last 90 days, totaling $5K.
No insider sales of BNGO were filed in the last 90 days.
This page tracks BNGO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add BNGO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
